Information:
Fel:
ID
15727
Beskrivning
Fatty Liver Disease in Obese Children; ODM derived from: https://clinicaltrials.gov/show/NCT02117700
Länk
https://clinicaltrials.gov/show/NCT02117700
Nyckelord
Versioner (1)
- 2016-06-09 2016-06-09 -
Uppladdad den
9 juni 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Obesity NCT02117700
Eligibility Obesity NCT02117700
- StudyEvent: Eligibility
Similar models
Eligibility Obesity NCT02117700
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
age 7 years and older
boolean
C0001779 (UMLS CUI [1])
Nonalcoholic Steatohepatitis | Biopsy Previous
Item
nash confirmed in a previous biopsy
boolean
C3241937 (UMLS CUI [1])
C0005558 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0005558 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Glycosylated hemoglobin A
Item
hbaic <6.4%
boolean
C0019018 (UMLS CUI [1])
Alanine aminotransferase measurement
Item
alt > 60 u/l or 1.5 times the upper limit of normal
boolean
C0201836 (UMLS CUI [1])
Chronic liver disease | alpha 1-Antitrypsin Deficiency | Hepatolenticular Degeneration | Hepatitis, Autoimmune | Viral hepatitis
Item
chronic liver disease including alpha-1-antitrypsin deficiency, wilson's disease, autoimmune and viral hepatitis
boolean
C0341439 (UMLS CUI [1])
C0221757 (UMLS CUI [2])
C0019202 (UMLS CUI [3])
C0241910 (UMLS CUI [4])
C0042721 (UMLS CUI [5])
C0221757 (UMLS CUI [2])
C0019202 (UMLS CUI [3])
C0241910 (UMLS CUI [4])
C0042721 (UMLS CUI [5])
Pharmaceutical Preparations Interferes with Measurement of liver enzyme | Pharmaceutical Preparations Risk factors Cardiovascular Diseases | Adrenergic beta-Antagonists | Steroids
Item
medications such as adrenergic β-blockers, steroids and other drugs known to interfere with the measurement of liver enzymes and risk factors for cardiovascular disease
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0428321 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0035648 (UMLS CUI [2,2])
C0007222 (UMLS CUI [2,3])
C0001645 (UMLS CUI [3])
C0038317 (UMLS CUI [4])
C0521102 (UMLS CUI [1,2])
C0428321 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0035648 (UMLS CUI [2,2])
C0007222 (UMLS CUI [2,3])
C0001645 (UMLS CUI [3])
C0038317 (UMLS CUI [4])
Heart Diseases | Chronic Kidney Diseases | Dysfunction adrenal | Liver Dysfunction | Thyroid dysfunction | Malignant Neoplasms | Anemia
Item
heart disease, chronic renal disease, adrenal, hepatic or thyroid dysfunction; active malignancy; and anemia
boolean
C0018799 (UMLS CUI [1])
C1561643 (UMLS CUI [2])
C0549609 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C0348024 (UMLS CUI [5])
C0006826 (UMLS CUI [6])
C0002871 (UMLS CUI [7])
C1561643 (UMLS CUI [2])
C0549609 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C0348024 (UMLS CUI [5])
C0006826 (UMLS CUI [6])
C0002871 (UMLS CUI [7])
Prior Therapy Acetylcysteine
Item
history of prior treatment with nac
boolean
C1514463 (UMLS CUI [1,1])
C0001047 (UMLS CUI [1,2])
C0001047 (UMLS CUI [1,2])
Hypersensitivity Acetylcysteine
Item
evidence of hypersensitivity/allergy to nac
boolean
C0020517 (UMLS CUI [1,1])
C0001047 (UMLS CUI [1,2])
C0001047 (UMLS CUI [1,2])
Substance Use Disorders | Smoking
Item
alcoholism or drug abuse and smoking
boolean
C0038586 (UMLS CUI [1])
C0037369 (UMLS CUI [2])
C0037369 (UMLS CUI [2])
Intercurrent disease
Item
inter-current illness over 7 days before the study & surgery in the past 3 mo.
boolean
C0277557 (UMLS CUI [1])